PUBLICATION

Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults

Authors
Wiprich, M.T., Zanandrea, R., Altenhofen, S., Bonan, C.D.
ID
ZDB-PUB-200501-7
Date
2020
Source
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP   234: 108772 (Journal)
Registered Authors
Bonan, Carla Denise
Keywords
3-Nitropropionic acid, Huntington's disease, Locomotion, Memory, Zebrafish
MeSH Terms
  • Aggression/drug effects
  • Animals
  • Antihypertensive Agents/pharmacology
  • Behavior, Animal/drug effects*
  • Disease Models, Animal
  • Heart Rate/drug effects
  • Larva/drug effects
  • Locomotion/drug effects
  • Motor Activity/drug effects
  • Nitro Compounds/pharmacology*
  • Propionates/pharmacology*
  • Zebrafish/embryology
  • Zebrafish/physiology
PubMed
32353558 Full text @ Comp. Biochem. Physiol. C Toxicol. Pharmacol.
Abstract
Long-term treatment with 3-nitropropionic acid (3-NPA), a toxin derived from plants and fungi, may reproduce symptoms and biochemical characteristics of Huntington's disease (HD). Our study evaluated the effects of 3-NPA on the physiological and behavioral responses in zebrafish larvae and adults. Larvae exposed to 0.1, 0.2, or 0.5 mM 3-NPA exhibited an increase in heart rate at 2- and 5-days post-fertilization (dpf). There was a decrease in the ocular distance at 5 dpf with 0.05 mM 3-NPA treatment. However, 3-NPA did not alter larval locomotor parameters. Adult zebrafish received 3-NPA intraperitoneal injections (a total of seven injections at doses 10, 20, or 60 mg/kg every 96 h) and showed a decrease in weight loss, locomotion and aggressive behavior. No changes were observed in anxiety-like behavior and social interaction between 3-NPA-exposed animals and control groups. However, 3-NPA-treated animals (at 60 mg/kg) demonstrated impaired long-term aversive memory. Overall, 3-NPA exposure induced morphological and heart rate alterations in zebrafish larvae. Additionally, our study showed behavioral changes in zebrafish that were submitted to long-term 3-NPA treatment, which could be related to HD symptoms.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping